首页> 外文期刊>Human vaccines & immunotherapeutics. >A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian
【24h】

A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historian

机译:西班牙流感的可能欧洲起源和第一次减少对抗超育细菌的死亡率的尝试:来自病毒学家和军事历史学家的意见

获取原文
获取原文并翻译 | 示例
       

摘要

When we reconsider the virology and history of the Spanish Influenza Pandemic, the science of 2018 provides us with tools which did not exist at the time. Two such tools come to mind. The first lies in the field of 'gain of function' experiments. A potential pandemic virus, such as influenza A (H5N1), can be deliberately mutated in the laboratory in order to change its virulence and spreadability. Key mutations can then be identified. A second tool lies in phylogenetics, combined with molecular clock analysis. It shows that the 1918 pandemic virus first emerged in the years 1915-1916. We have revisited the literature published in Europe and the United States, and the notes left by physicians who lived at the time. In this, we have followed the words of the late Alfred Crosby: who wrote that "contemporary documentary evidence from qualified physicians" is the key to understanding where and how the first outbreaks occurred. In our view, the scientists working in Europe fulfill Crosby's requirement for contemporary evidence of origin. Elsewhere, Crosby also suggested that "the physicians of 1918 were participants in the greatest failure of medical science in the twentieth century". Ours is a different approach. We point to individual pathologists in the United States and in France, who strove to construct the first universal vaccines against influenza. Their efforts were not misdirected, because the ultimate cause of death in nearly all cases flowed from superinfections with respiratory bacteria.
机译:当我们重新考虑西班牙流感大流行病的病毒学和历史时,2018年的科学为我们提供了当时不存在的工具。两个这样的工具想到了。第一个位于“功能的增益”实验领域。潜在的大流行病病毒,例如流感A(H5N1),可以在实验室中刻意突变,以改变其毒力和扫描性。然后可以识别键突变。第二种工具位于系统发育中,结合分子时钟分析。它表明,1918年在1915年至1916年首次出现了1918年的大疱病毒。我们重新审视了欧洲和美国发表的文献,当时生活的医生留下的票据。在这方面,我们遵循了阿尔弗雷德克罗斯比末期的话:谁写道,“来自合格的医生的当代纪录片证据”是了解第一次爆发的何处和如何发生的关键。在我们看来,在欧洲工作的科学家们履行了Crosby对当代原产地证据的要求。其他地方,克罗斯比还建议,“1918年的医生是二十世纪医学科学最大的参与者”。我们是一种不同的方法。我们指出了美国和法国的个体病理学家,他努力建造了针对流感的第一个通用疫苗。他们的努力没有误导,因为几乎所有患用病因都是从呼吸细菌的超育症流动的终极原因。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号